An activity-based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti-fibrotic therapeutic strategies

MeSH terms

• Amino Acid Oxidoreductases / analysis
• Amino Acid Oxidoreductases / pharmacology*
• Amino Acid Oxidoreductases / therapeutic use
• Antifibrotic Agents / analysis
• Antifibrotic Agents / pharmacology*
• Antifibrotic Agents / therapeutic use
• Biosensing Techniques / instrumentation*
• Biosensing Techniques / methods
• Biosensing Techniques / standards*
• Fibrosis / drug therapy
• Fibrosis / prevention & control
• Humans